Abstract
Purpose of Review: Multiple studies report an increased incidence of diabetes following SARS-CoV-2 infection. Given the potential increased global burden of diabetes, understanding the effect of SARS-CoV-2 in the epidemiology of diabetes is important. Our aim was to review the evidence pertaining to the risk of incident diabetes after COVID-19 infection. Recent Findings: Incident diabetes risk increased by approximately 60% compared to patients without SARS-CoV-2 infection. Risk also increased compared to non-COVID-19 respiratory infections, suggesting SARS-CoV-2-mediated mechanisms rather than general morbidity after respiratory illness. Evidence is mixed regarding the association between SARS-CoV-2 infection and T1D. SARS-CoV-2 infection is associated with an elevated risk of T2D, but it is unclear whether the incident diabetes is persistent over time or differs in severity over time. Summary: SARS-CoV-2 infection is associated with an increased risk of incident diabetes. Future studies should evaluate vaccination, viral variant, and patient- and treatment-related factors that influence risk.
Original language | English (US) |
---|---|
Pages (from-to) | 207-216 |
Number of pages | 10 |
Journal | Current diabetes reports |
Volume | 23 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2023 |
Bibliographical note
Publisher Copyright:© 2023, The Author(s).
Keywords
- COVID-19
- Incident diabetes
- SARS-CoV-2
- Type 1 diabetes
- Type 2 diabetes
PubMed: MeSH publication types
- Journal Article
- Review
- Research Support, N.I.H., Extramural